Prophylaxis of chemotherapy-induced vomiting and nausea;A kemoterápia okozta hányás csillapítása

Magyar Onkologia

Volumn 52, Issue 4, 2008, Pages 391-394

  Tóth, Judit ^a   Szántó, János ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

5 HT3 receptor antagonists; Chemotherapy induced vomiting and nausea

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; APREPITANT; CORTICOSTEROID; GRANISETRON; MORPHOLINE DERIVATIVE; NEUROKININ 1 RECEPTOR; ONDANSETRON; SEROTONIN 3 RECEPTOR;

CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; HUMAN; METHODOLOGY; NAUSEA; PRIMARY PREVENTION; REVIEW; TIME; VOMITING;

ADRENAL CORTEX HORMONES; ANTIEMETICS; ANTINEOPLASTIC AGENTS; GRANISETRON; HUMANS; MORPHOLINES; NAUSEA; ONDANSETRON; PRIMARY PREVENTION; RECEPTORS, NEUROKININ-1; RECEPTORS, SEROTONIN, 5-HT3; TIME FACTORS; VOMITING;

EID: 59849112624     PISSN: 00250244     EISSN: 20600399     Source Type: Journal    
DOI: 10.1556/MOnkol.52.2008.4.9     Document Type: Article

References (15)

1. Coates A, Abraham S, Kaye SB, et al. On the receiving end-patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19:203-208, 1983
2. Hesketh PJ, van Belle S, Aapro M, et al. Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur J Cancer 39:1074-1080, 2003
3. Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Eng J Med 358:2482-2494, 2008
4. Jordan K, Hinke A, Grothey A, et al. A meta-Analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis. Support Care Cancer 15:1023-1033, 2007
5. Hesketh PJ, Grunberg SM, Gralla RJ, et al. The oral neurokinin antagonist aprepitant for the prevention of chemotherapy.induced nausea and vomiting: a multinational, randomised, double-blind, placebo-controlled trial in patient receiving high-dose cisplatinthe Aprepitant protocol 052 Study Group. J Clin Oncol 21:4112-4119, 2003
6. Ioannidis JP, Hesketh PJ, Lau J. Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-Analysis of randomized evidence. J Clin Oncol 18:3409-3422, 2000
7. Kris MG, Tyson LB, Gralla RJ, et al. Extrapyramidal reactions with high-dose metoclopramine. N Eng J Med 309:433-437, 1983
8. Laszlo J, Clark RA, Hanson DC, et al. Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects. J Clin Oncol 3:864-869, 1985
9. Grosseman B, Lessin L S, Cohen P. Droperidol prevents nausea and vomiting from cis-platinum. N Engl J Med 301:47, 1979
10. Tramèr MR, Carroll D, Campbell FA, et al. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323:16-21, 2001
11. Morrow GR. Prevalence and correlates of anticipatory nausea and vomiting in chemotherapy patients. J Natl Cancer Inst 68:585-588, 1982
12. American Society of Clinical Oncology, Kris MG, Hesketh PJ, Somerfield MR, et al. American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006. J Clin Oncol 24:2932-2947, 2006
13. NCCN: Practice Giudelines in Oncology: Antiemesis. v.3. 2008
14. Herrstedt J, Roila H. Chemotherapy-induced nausea and vomiting: ESMO, Clinical Recommendations for prophylaxis. Ann Oncol 19(Suppl. 2):110-112, 2008
15. Herrstedt J. Antiemetics: an update and the Multinational Association of Supportive Care in Cancer (MASCC) guidelines applied in clinical practice. Nat Clin Pract Oncol 5:32-43, 2008